XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Operating expenses:        
Research and development $ 18,590 $ 28,922 $ 37,377 $ 49,650
General and administrative 7,541 8,948 15,275 16,411
Total operating expenses 26,131 37,870 52,652 66,061
Loss from operations (26,131) (37,870) (52,652) (66,061)
Other income (expense):        
Interest income 6,086 841 11,065 1,798
Investment advisory fees (231) (215) (461) (384)
Change in fair value of warrant liability (265) 3,080 (123) 9,404
Realized loss on marketable securities (99) (694) (195) (908)
Total other income (expense), net 5,491 3,012 10,286 9,910
Loss before income taxes (20,640) (34,858) (42,366) (56,151)
Provision for income taxes 0 0 0 0
Net loss $ (20,640) $ (34,858) $ (42,366) $ (56,151)
Net loss per share attributable to common stockholders, basic $ (0.09) $ (0.16) $ (0.19) $ (0.26)
Net loss per share attributable to common stockholders, diluted $ (0.09) $ (0.16) $ (0.19) $ (0.26)
Weighted average common shares outstanding, basic 218,848 216,603 218,795 215,016
Weighted average common shares outstanding, diluted 218,848 216,603 218,795 215,016
Comprehensive loss:        
Net loss $ (20,640) $ (34,858) $ (42,366) $ (56,151)
Other comprehensive loss, net of taxes:        
Change in unrealized (loss) gain on available-for-sale securities (1,457) (761) 1,131 (5,793)
Comprehensive loss $ (22,097) $ (35,619) $ (41,235) $ (61,944)